Welcome
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic
More
Pipeline Insight: Cancer Overview – Breast and Gynecological Cancers
Datamonitor, Dec 2010
Description
Table of Contents
Enquire before Buying
Send to a Friend
The 'Pipeline Insight: Cancer Overview – Breast and Gynecological Cancers' report is due to be published in December 2010.
This report will cover the following key topics:
- Pipeline Overview and Dynamics
- Epidemiology
- Market overview
- R&D Approach
- Pipeline Analysis & Forecasts: Breast
- Pipeline Analysis & Forecasts: Ovarian
- Pipeline Analysis & Forecasts: Cervical
- Innovative Early-Stage Approaches
This report pack includes the Full report (pdf), Datapack (xls) and Executive presentation (ppt)
Customers who bought this item also bought
Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
Pipeline Insight: Lung Cancers Overview - Intensive R&D activity but little improvement in patient outcomes
Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine Tumors and Thyroid Cancer - New drug approvals likely after decades of little progress
Pipeline and Commercial Insight: Neuropathic Pain - Pipeline setbacks prolong Pfizer's supremacy
Pipeline Insight: Moderate-to-Severe Acute Pain - Positive outlook for opioid-sparing analgesics
Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic gastrointestinal cancers represent a significant commercial opportunity due to a lack of approved drugs
Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis
Competitor Analysis: Antibody-Drug Conjugates (ADC) 2010 Update
Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline
For enquiries please call us on:
+353-1-415-1241
(GMT Office Hours)
1-800-526-8630
(US/Canada Toll Free)
1-917-300-0470
(EST Office Hours)
All rights reserved. © Copyright 2012 Research and Markets
2
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
Affiliate Network
